2022年ASTCT-CIBMTR移植与细胞冶疗会议
遗传研讨会|移植展览会|血液学活动|
会议地点: 美国 盐湖城（Salt Lake City, UT）
会议时间: 2022年2月2日至6日
行业: 遗传|移植|血液学会议
会议简介:
2022年美国ASBMT-CIBMTR移植与细胞冶疗年会（串联会议）将于2022年2月2日至6日在美国犹他州盐湖城举行。ASBMT-CIBMTR移植与细胞冶疗会议（年会）将介绍血液和骨髓移植以及细胞治疗各个领域的基础科学、转化研究和临床研究宣的最新进展，预计今年将有超过3,700名代表与会。
Tandem Meetings|ASBMT-CIBMTR移植和细胞治疗会议(BMT串连会议)，是美国移植与细胞治疗学会(ASTCT)和国际血液和骨髓移植研究中心(CIBMTR)联合举办的年度会议，首届BMT串连会议于1995年举行。
2022 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR
February 2-6, 2022
Salt Lake City, UT, USA
Tandem Meetings | Transplantation and Cellular Therapy Meetings (formerly the BMT Tandem Meetings) are the combined annual meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR). Investigators, clinicians, laboratory technicians, clinical research professionals, nurses, pharmacists, administrators and allied health professionals benefit from the full scientific program that addresses the most timely issues in hematopoietic cell transplantation.
摘要征集：
- Abstract Submission Deadline: Monday, October 4, 2021
- Abstract Accept/Reject Notification: End of November 2021
- Late Breaking Abstract Submissions: November 22 - December 6, 2021
Work submitted for presentation should not have been reported previously in an archival scientific publication, either as an article or as an abstract, at the time of submission. Data that has been, or will be, presented at any other meeting before being presented at the 2022 Tandem Meetings of ASTCT and CIBMTR, will not be accepted for presentation.
Due to the overlap in abstract submission and notification timelines for the 2021 ASH Annual Meeting, data submitted to the 2021 ASH Annual Meeting is acceptable for submission to the 2022 Tandem Meetings of ASTCT and CIBMTR. Please note that the Tandem Meetings Scientific Organizing Committee has final say on whether an abstract presented at the 2021 ASH Meeting will be eligible for presentation at the 2022 Tandem Meetings.
Conference Registration FeeAbstract presenting authors will be eligible for the Early Registration Rate even after Standard and On-Site registration rates apply.
Abstract Submission Fee-摘要提交费
There is a $50 non-refundable abstract submission fee.
Abstract Categories
Abstract data/research must apply to one of the following categories:
- Acute and chronic leukemia (AML, MDS, MPD ALL, CML, CLL) - Basic/preclinical
- Acute and chronic leukemia (AML, MDS, MPD ALL, CML, CLL) - Clinical
- Acute Regimen-Related Toxicity and Supportive Care
- CAR-T - Basic: Antigen Finding, Safety, Effector Cells
- CAR-T - Clinical: Regulatory, Efficacy, Persistence
- Cellular and Gene therapy: Basic/preclinical
- Cellular and Gene therapy: Clinical, processing
- Conditioning regimens
- Donor Health and Safety
- Graft Sources (related, matched and mismatched unrelated, haplo, autologous, cord blood, bone marrow and peripheral blood)
- Graft-versus-Host and graft versus tumor - Basic/preclinical
- Graft-versus-Host and graft versus tumor - Clinical: Prevention, treatment and biomarkers
- Health Services
- Hematopoietic stem cell niche, biology, expansion
- Hemoglobinopathies, Primary Immune deficiencies and Inborn Errors of Metabolism - Basic/preclinical
- Hemoglobinopathies, Primary Immune deficiencies and Inborn Errors of Metabolism - Clinical
- HSCT for autoimmune disorders
- HSCT, gene and other cellular therapies in countries with constrained resources
- Immune reconstitution and Immunobiology
- Immunogenetics
- Infectious Diseases and Cytotoxic T lymphocytes
- IT and Informatics for Transplant and Cellular Therapy (CIBMTR)
- Late Effects and Quality of Life
- Lymphoma/myeloma - Basic/preclinical
- Lymphoma/myeloma - Clinical
- Marrow failure syndromes (congenital and acquired)
- Advanced Practice Professionals (for Advance Practice Provider Track)
- Relapse - Basic/preclinical
- Relapse - Clinical: Prevention and Treatment
- Quality and Transplant Program Administration (for Administrative Director Track)
- Study design and statistics
- Transplant and Cell Therapy for Aged and Geriatric Populations
- Transplantation Data Management (for Clinical Research Professionals/Data Managers Track)
- Transplantation Pharmacology (for Pharmacists Track)
- Administration
- Clinical
- Education
- Research
The first author listed for each abstract serves as the Presenting Author and is the primary contact for all correspondence regarding the abstract.
The Presenting Author is responsible for the following:
- Ensuring that all authors have read the abstract and agreed to be co-authors.
- Notifying all co-authors of any additions, deletions, and changes to the program, as may be communicated by the Tandem Meetings of ASTCT and CIBMTR.
- Obtaining all of the conflict-of-interest disclosure information from co-authors.
- Making certain that abstracts are complete (tables included and labeled) and written in clear, concise and grammatically correct English, so that reviewers are able to focus solely on the scientific merits of the submission. For authors with any questions regarding the clarity, grammar, or spelling of their abstract, we encourage identifying and using an independent reviewer to edit the abstract prior to submission.
- Ensuring that they will be prepared to present and to respond to questions regarding the abstract. If that is not the case, the authors should choose a poster as their preference.
Each abstract author agrees and certifies that they:
- Have read all of the rules and agrees to be bound by them.
- Are responsible for submission of the abstract in accordance with the rules, and waives any and all claims against ASTCT/CIBMTR/Tandem Meetings of ASTCT and CIBMTR and any reviewer arising out of or relating to the abstract submission and review process, including but not limited to peer review and the grading of abstracts.
Abstract Review
Abstracts are peer reviewed on their scientific merits and according to subject category. Individuals submitting abstracts must indicate the appropriate review category. Abstracts may be re-categorized to a more appropriate category based on guidance from the Tandem Meetings Co-Chairs. The ASTCT, CIBMTR and Tandem Meetings of ASTCT and CIBMTR reserve the right to make minor editorial grammatical/spelling changes if required for clarity of presentation..
Abstract Corrections
All changes/edits to submitted abstracts are strictly the responsibility of the first author and must be conducted within the confines of the abstract submission portal. Requests for assistance in accessing abstracts to allow for modifications, should be submitted in writing to [email protected].
Abstract Withdrawals
Abstract withdrawals can be made within the submission system by the first author, no later than Friday, October 29, 2021 pm PT.
Abstract withdrawal requests after Friday, October 29, 2021 pm PT must be made, in writing only, to [email protected]. ASTCT and CIBMTR Staff cannot fulfill any withdrawal requests by phone. Accepted abstracts that remain in the submission system on November 16, 2021 may be published online and in ASTCT's journal, Transplantation and Cellular Therapy, as submitted.
Incomplete Abstracts
Any submitted abstract deemed incomplete within the submission system on October 5, 2021 at 12:01 am PT will be eliminated without further notification prior to abstracts being distributed to the 2022 Tandem Meetings abstract review team.
Late-Breaking Abstracts
The submission of late-breaking abstracts will be allowed from November 22, 2021 – December 6, 2021 at 11:59 pm PT.
Late-breaking abstract authors must complete a request for information to explain the need for submission during the late-breaking abstract submission process, which will be shared with the abstract reviewers and program Co-Chairs.
Embargo
Abstracts submitted for presentation will be embargoed by the author(s) and the 2021 TCT Meetings Digital Experience, upon submission.
Abstracts submitted for presentation to the 2022 Tandem Meetings will be embargoed by the author(s) and the 2022 Tandem Meetings, upon submission. The embargo will be lifted and abstracts will be made available for viewing on January 7, 2022 PT.
注册费：
|
In-Person Attendee Experience
In-Person Attendee also has access to all the items the Online Attendee receives |
Online Attendee Experience |
| Face-to-Face |
Live Stream experience for various sessions |
| Live Interaction with all sessions |
Access to receive continuing education credits for up to 30 days post meeting |
| Opening reception in the exhibit hall |
Ability to view recordings of most educational sessions in the On-Demand Library |
| Poster sessions |
Access to view posters via the online agenda. |
| Closing Reception |
Connect via the mobile app |
| Food and Beverage |
Interaction via Q&A |
Registration Schedule and Fees
|
Available through December 14 |
Effective December 15 |
Online Attendee | |
ASTCT or CIBMTR Member |
$595 |
$795 |
$295 |
|
Non-Member |
$895 |
$1,095 |
$595 |
|
Fellow and/or In-Training |
$195 |
$245 |
$100 |
|
*member rates |
$250 |
$295 |
$150 |
|
*non-member rates |
$450 |
$495 |
$295 |
| IT Professional *member rates |
$250 |
$295 |
$150 |
IT Professional *non-member rates |
$450 |
$495 |
$295 |
|
Press |
$0 |
$0 |
$0 |
|
Exhibitor Only *no session or continuing education access |
$300 |
$300 |
N/A |
|
Exhibitor *Includes session or continuing education access |
$450 |
$495 |
N/A |
|
Spouse/Guest |
$85/day |
$85/day |
N/A |
| Event Add-ons |
Available through December 14 |
Effective December 15 |
| Tandem Reception Ticket - Physician and/or PhD |
$60 |
$75 |
| Tandem Reception Ticket - Allied Health Professionals, Fellows and/or In-Training, Spouse/Guest |
$45 |
$59 |
| Tandem Reception: Block of 10 Tickets |
$480 |
$600 |
|
*In-person session tickets can only be purchased onsite |
$40 |
$40 |
|
*In-person session tickets can only be purchased onsite |
$35 |
$35 |
会议对象: 医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
免责条款：本站信息均收集整理自互联网，访问者如需了解更多详情，请进入相关活动官网，本站不对相关信息的准确性承担任何责任； 若本站的资讯侵害您的权益，请发送邮件到[email protected]，本站将在核实相关情况后第一时间删除。继续访问本站视为认同以上条款。
更多会议活动:
2018年第16届国际脐带血研讨会(ICBS)
2023年IPITA-IXA-CTRMS联席会议
中国医师协会2021中国器官移植大会暨/第八届中国器官移植医师年会
2022年韩国血液学会国际会议/第64届年会
2022年第11届国际儿科移植协会(IPTA)大会
2020年美国血液学会(ASH)淋巴瘤生物学会议
第73届美国国家血友病基金会出血性疾病大会/年会(NHF-BDC2021)
中国病理生理学会第十八届全国实验血液学学术会议
中国医师协会第十五届血液科医师年会暨2021年中国血液病大会
2022年美国移植大会(ATC)
